Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Mynaric Receives Receipt Of Deficiency Letter From Nasdaq

Author: Benzinga Newsdesk | January 29, 2025 03:20pm

Mynaric (NASDAQ:MYNA)(FRA:M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, announces that it received a notification letter dated January 23, 2025 (the "Deficiency Letter") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq") notifying that Mynaric is no longer in compliance with the Nasdaq continued listing criteria, including the Nasdaq Listing Rule 5450(a)(1) due to its failure to meet the minimum closing bid price per share of Mynaric's American Depositary Shares representing its ordinary shares (the "ADS") of $1.00 for a period of 30 consecutive business days (the "Minimum Bid Price Requirement").

The Deficiency Letter has no immediate effect on the listing of Mynaric's ADS, which continue to trade under the symbol "MYNA."

Posted In: MYNA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist